Thiotepa
THIOTEPA RIEMSER 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
In other countries
The same active substances on other registers, the same brand first.
Authorised centrally in the EU
This national listing belongs to a medicine the European Commission authorised for the whole EU.
- Thiotepa RiemserCroatiaSame brand
- Thiotepa MedacItaly · Polvere per concentrato per soluzione per infusione · Medac Gesellschaft Fur Klinische Spezialpraparate MBHSame brand
- Thiotepa RiemserItaly · Polvere per concentrato per soluzione per infusione · Esteve Pharmaceuticals GmbHSame brand
- Thiotepa MSNSerbia · 100mg · prašak za koncentrat za rastvor za infuziju · Pharmas D.O.O. BeogradSame brand
- Thiotepa MSNSerbia · 100mg · prašak za koncentrat za rastvor za infuziju · Pharmas D.O.O. BeogradSame brand
- TepadinaItaly · Polvere e solvente per soluzione per infusione endovenosa · Adienne S.R.L. S.U.Same form
- Tepadina 100 mg, poeder voor oplossing voor infusieNetherlands · Poeder voor oplossing voor infusie · Adienne S.r.l.Same form
- Tepadina 15 mg, poeder voor oplossing voor infusieNetherlands · Poeder voor oplossing voor infusie · Adienne S.r.l.Same form
- Tepadina 200 mg poeder en oplosmiddel voor oplossing voor infusieNetherlands · Poeder en oplosmiddel voor oplossing voor infusie · Adienne S.r.l.Same form
- BedfordNew Zealand · Inj 15 mg vialSame form
- Max HealthNew Zealand · Inj 100 mg vialSame form
- Max HealthNew Zealand · Inj 15 mg vialSame form
- Tepadina Powder for Concentrate for Solution for Infusion 100MG/VialSingapore · 100mg/vial · injection, powder, lyophilized, for solution · Axxessbio Pte. LTD.Same form
- Tepadina Powder for Concentrate for Solution for Infusion 15MG/VialSingapore · 15mg/vial · injection, powder, lyophilized, for solution · Axxessbio Pte. LTD.Same form
- Thiotepa Riemser Powder for Concentrate for Solution for Infusion 100MG/VialSingapore · 100.0 mg/vial · injection, powder, lyophilized, for solution · Nyprax Pharma Pte. LTD.Same form
- ThiotepaUnited States · 15MG/VIAL, 15MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · DR ReddysSame form
- ThioplexUnited States · 15MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · ImmunexSame form
- DipateBrazil · Mawdsleys Pharmaceuticals do Brasil LtdaSame substance
- TepadinaCanada · 100 MG / VIAL · Powder For Solution · Adienne SASame substance
- TepadinaCanada · 15 MG / VIAL · Powder For Solution · Adienne SASame substance
- Thiotepa for Injection, BPCanada · 100 MG / VIAL · Powder For Solution · Hikma Canada LimitedSame substance
- TepadinaEuropean Union · ADIENNE S.r.l. S.U.Same substance
- Thiotepa RiemserEuropean Union · Esteve Pharmaceuticals GmbHSame substance
- Tiotepa Fresenius Kabi 100 mg prašak za koncentrat za otopinu za infuzijuCroatia · Prašak za koncentrat za otopinu za infuziju · Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, HrvatskaSame substance
- Tiotepa MSN 100 mg prašak za koncentrat za otopinu za infuzijuCroatia · Prašak za koncentrat za otopinu za infuziju · MSN Labs Europe Limited, Kw20a Corradino Park, Paola, MaltaSame substance
- TEPADINA 100mgRomania · 100mg · pulb. pt. conc. pt. sol. perf. · Adienne SRL SuSame substance
- TEPADINA 15mgRomania · 15mg · pulb. pt. conc. pt. sol. perf. · Adienne SRL SuSame substance
- ApetoSaudi Arabia · MSN Laboratories Private LimitedSame substance
- ApetoSaudi Arabia · MSN Laboratories Private LimitedSame substance
- TepadinaSaudi Arabia · BSP PharmaceuticalsSame substance
- TepadinaUnited States · 100MG/VIAL, 15MG/VIAL · powder · Adienne SASame substance
Packs
| Pack | Code | Status |
|---|---|---|
| THIOTEPA RIEMSER 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 730837 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Thiotepa
- Strength
- 100 mg
- Dosage form
- polvo para concentrado para solución para perfusión
- Route
- vía intravenosa
- Register
- Spain (AEMPS)
- Status
- Marketed
- Status in the register
- Autorizado, comercializado
- Authorised
- 10 May 2021
- Registration
- 1211536002
- Marketing authorisation holder
- Esteve Pharmaceuticals Gmbh
- Procedure
- EU centralised
- Supply
- Uso Hospitalario
- EU number
- EU/1/21/1536



